Group One Trading, L.P. Bei Gene, Ltd. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$179.87 - $225.13 $17,987 - $22,513	100 Added 64.52%	255 $45,000
Q2 2023 Aug 09, 2023	BUY	$178.3 - $266.78 $27,636 - $41,350	155 New	155 $27,000
Q3 2022 Nov 09, 2022	BUY	$131.8 - $202.24 $39,540 - $60,672	300 New	300 $40,000
Q1 2022 May 12, 2022	SELL	$146.52 - $269.56 $217,289 - $399,757	-1,483 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$248.56 - $389.34 $368,614 - $577,391	1,483 New	1,483 $402,000
Q3 2021 Nov 12, 2021	SELL	$249.6 - $403.14 $115,564 - $186,653	-463 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$292.75 - $367.01 $135,543 - $169,925	463 New	463 $159,000
Q1 2021 May 12, 2021	SELL	$260.64 - $382.12 $1.43 Million - $2.1 Million	-5,497 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$221.31 - $316.61 $441,956 - $632,270	1,997 Added 57.06%	5,497 $1.42 Million
Q3 2020 Nov 12, 2020	SELL	$189.18 - $286.44 $209,611 - $317,375	-1,108 Reduced 24.05%	3,500 $1 Million
Q2 2020 Aug 13, 2020	BUY	$123.9 - $195.41 $359,557 - $567,079	2,902 Added 170.11%	4,608 $868,000
Q1 2020 May 13, 2020	SELL	$121.84 - $173.19 $651,478 - $926,046	-5,347 Reduced 75.81%	1,706 $210,000
Q4 2019 Feb 10, 2020	BUY	$115.78 - $208.34 $724,898 - $1.3 Million	6,261 Added 790.53%	7,053 $1.17 Million
Q3 2019 Nov 12, 2019	BUY	$120.61 - $148.29 $95,523 - $117,445	792 New	792 $97,000
Q1 2019 May 13, 2019	SELL	$122.82 - $151.83 $395,971 - $489,499	-3,224 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$107.01 - $175.15 $11,557 - $18,916	108 Added 3.47%	3,224 $452,000
Q3 2018 Nov 08, 2018	BUY	$152.62 - $189.66 $373,155 - $463,718	2,445 Added 364.38%	3,116 $537,000
Q2 2018 Aug 14, 2018	BUY	$152.5 - $216.77 $102,327 - $145,452	671 New	671 $103,000

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$2.03 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.24 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$995 Million
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$956 Million
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$712 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.9B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account